We are live on ! Find out more
VRM

Vectors Research Management Portfolio holdings

AUM $383M
1-Year Est. Return 30.23%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+30.23%
3 Year Est. Return
+67.25%
5 Year Est. Return
+74.92%
10 Year Est. Return
AUM
$363M
AUM Growth
+$37.5M
Cap. Flow
+$23.3M
Cap. Flow %
6.41%
Top 10 Hldgs %
37.51%
Holding
493
New
45
Increased
101
Reduced
101
Closed
47
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$213B
$3.94M 1.09%
8,632
+104
+1% +$49.6K
NVDA icon
27
NVIDIA
NVDA
$4.86T
$3.92M 1.08%
293,520
-6,320
-2% -$84.9K
HD icon
28
Home Depot
HD
$331B
$3.8M 1.05%
12,438
+779
+7% +$215K
EQIX icon
29
Equinix
EQIX
$101B
$3.77M 1.04%
5,541
-21
-0.4% -$14.4K
FNY icon
30
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$578M
$3.23M 0.89%
47,472
+3,583
+8% +$249K
IBM icon
31
IBM
IBM
$211B
$3.13M 0.86%
24,600
-431
-2% -$51.6K
MRSH
32
Marsh
MRSH
$90.5B
$2.82M 0.78%
23,176
-248
-1% -$28.6K
FISV
33
Fiserv Inc
FISV
$28.8B
$2.78M 0.77%
23,350
-292
-1% -$33.5K
BNL icon
34
Broadstone Net Lease
BNL
$4.11B
$2.64M 0.73%
+144,224
New +$2.66M
VCSH icon
35
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$2.64M 0.73%
31,982
-5,481
-15% -$454K
VBK icon
36
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
$2.58M 0.71%
9,385
+363
+4% +$102K
CVS icon
37
CVS Health
CVS
$133B
$2.56M 0.7%
33,962
+1,544
+5% +$112K
LOW icon
38
Lowe's Companies
LOW
$117B
$2.43M 0.67%
12,795
+838
+7% +$144K
ALB icon
39
Albemarle
ALB
$13.9B
$2.37M 0.65%
16,198
+720
+5% +$116K
SPY icon
40
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$2.36M 0.65%
5,955
-1,850
-24% -$713K
CMCSA icon
41
Comcast
CMCSA
$85B
$2.26M 0.62%
41,725
-3,111
-7% -$164K
VO icon
42
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$2.16M 0.59%
39,004
-3,988
-9% -$216K
D icon
43
Dominion Energy
D
$60.8B
$2.16M 0.59%
28,381
+2,220
+8% +$161K
DUK icon
44
Duke Energy
DUK
$97.8B
$2.05M 0.57%
21,266
+636
+3% +$58K
ORCL icon
45
Oracle
ORCL
$374B
$1.94M 0.54%
27,684
+1,784
+7% +$116K
TGT icon
46
Target
TGT
$65.6B
$1.93M 0.53%
9,719
+3,575
+58% +$669K
ACN icon
47
Accenture
ACN
$102B
$1.88M 0.52%
6,795
SO icon
48
Southern Company
SO
$109B
$1.78M 0.49%
28,713
-225
-0.8% -$13.5K
IJH icon
49
iShares Core S&P Mid-Cap ETF
IJH
$122B
$1.77M 0.49%
34,020
-190
-0.6% -$9.49K
INTC icon
50
Intel
INTC
$455B
$1.65M 0.45%
25,705
+8
+0% +$477

Similar funds

Vectors Research Management's Q1 2021 Portfolio in Review

As of Q1 2021, Vectors Research Management held 493 positions worth $363M, up 12% from $325M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Vectors Research Management deployed $23.3M of net new capital in Q1 2021, opening 45 new positions and adding to 101 existing holdings. Its largest new stake was Broadstone Net Lease: 144,224 shares worth $2.64M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $2.64M trimmed.

  • Vectors Research Management's largest Q1 2021 buy was Broadstone Net Lease: 144,224 shares worth $2.64M.
  • Vectors Research Management added most to iShares Floating Rate Bond ETF in Q1 2021, an estimated $4.91M increase.
  • Vectors Research Management's biggest Q1 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $2.64M.
  • Vectors Research Management fully exited Arena Pharmaceuticals Inc in Q1 2021, selling an estimated $282K.
  • Vectors Research Management's ten largest holdings make up 38% of its $363M portfolio in Q1 2021.
  • Vectors Research Management opened 45 new positions and closed 47 in Q1 2021.
  • Vectors Research Management's portfolio value rose 12% quarter-over-quarter to $363M.

Based on Vectors Research Management's 13F filing for Q1 2021, filed 18 May 2021.